Article Text

Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain
  1. J Chen1,
  2. G Wildhardt2,
  3. Z Zhong1,
  4. R Röth1,
  5. B Weiss1,
  6. D Steinberger2,
  7. J Decker2,
  8. W F Blum3,
  9. G Rappold1
  1. 1
    Department of Molecular Human Genetics, University of Heidelberg, Heidelberg, Germany
  2. 2
    Bioscientia Institute of Medical Diagnostics, Ingelheim, Germany
  3. 3
    Lilly Research Laboratories, Eli Lilly and Company, Bad Homburg, Germany
  1. Correspondence to ProfDr G A Rappold, Institute of Human Genetics, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany; gudrun.rappold{at}med.uni-heidelberg.de

Abstract

Background: Mutations and deletions of the homeobox transcription factor gene SHOX are known to cause short stature. The authors have analysed SHOX enhancer regions in a large cohort of short stature patients to study the importance of regulatory regions in developmentally relevant genes like SHOX.

Methods: The authors tested for the presence of copy number variations in the pseudoautosomal region of the sex chromosomes in 735 individuals with idiopathic short stature and compared the results to 58 cases with Leri–Weill syndrome and 100 normal height controls, using fluorescence in situ hybridisation (FISH), single nucleotide polymorphism (SNP), microsatellites, and multiplex ligand dependent probe amplification (MLPA) analysis.

Results: A total of 31/735 (4.2%) microdeletions were identified in the pseudoautosomal region in patients with idiopathic short stature; eight of these microdeletions (8/31; 26%) involved only enhancer sequences residing a considerable distance away from the gene. In 58 Leri–Weill syndrome patients, a total of 29 microdeletions were identified; almost half of these (13/29; 45%) involve enhancer sequences and leave the SHOX gene intact. These deletions were absent in 100 control persons.

Conclusion: The authors conclude that enhancer deletions in the SHOX gene region are a relatively frequent cause of growth failure in patients with idiopathic short stature and Leri–Weill syndrome. The data highlights the growing recognition that regulatory sequences are of crucial importance in the genome when diagnosing and understanding the aetiology of disease.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

Footnotes

  • Additional appendix and figure are published online only at http://jmg.bmj.com/content/vol46/issue12

  • Funding This work was supported by the Deutsche Forschungsgemeinschaft and the Land Baden-Württemberg. Jianjun Chen was supported by a grant of the postdoctoral fellowship program of the Faculty of Medicine, Heidelberg.

  • Competing interests GW, DS and JD are (or were) employees of the Bioscientia Institute of Medical Genetics, WB is an employee of Eli Lilly and company. GR is a patent owner and has been reimbursed by Eli Lilly for attending and speaking at several conferences. JC, ZZ, RR, and BW have no competing interests.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.